Understanding the rare disease alkaptonuria: the role of oxidative stress, inflammation and amyloidosis
Alkaptonuria (AKU) is an ultra-rare disease that was recognized among the first inborn errors of metabolism. In AKU, an altered activity of the enzyme homogentisate 1,2-dioxygenase (HGD) occurring upon gene mutation lead to a defective metabolism of the aromatic amino acids Tyrosine and Phenylalanine. Such a defect causes the accumulation of a metabolite, namely homogentisic acid (HGA), in body fluids. It is known that HGA can undergo spontaneous oxidation into a benzoquinone acetate (BQA) compound, followed by polymerization (through still unknown mechanisms) into brown-black (ochronotic) pigments.
AKU manifests through a characteristic temporally related triad of symptoms due to the presence of HGA, such as:
- Excretion of HGA with urine (turning black upon standing, hence the name of ‘black urine disease’)
- Ochronosis (bluish-black discolouration of connective tissues in eyes, ears, joints, cardiac valves… hence the name of ‘black bone disease’)
- Early-onset arthritis-like damage due to deposition of an ochronotic pigment in joints and spine, which causes severe pain and greatly reduces patients’ quality of life.
Similarly to many other rare conditions, however, the paucity of cases and difficulties in collecting and studying patients’ samples hindered the clarification of the molecular mechanisms of AKU. To overcome this problem, we established a range of human serum-, cell- and tissue- based human models to reproduce and analyse under controlled laboratory conditions the effects of HGA and BQA. These models revealed unequivocally that HGA and BQA toxicity was mediated by oxidative stress, inflammation and amyloidosis.
Oxidative stress in AKU
Protein carbonyls are considered major hallmarks of oxidative stress. We showed that HGA can increase protein carbonyls in a chondrocytic cell line in vitro, and found that oxidation was mainly directed towards proteins with structural functions, involved in protein folding, and proteins of the stress response. Chondrocytes from AKU donors showed a similar pattern of oxidation. Analogously, human serum showed an increased protein carbonylation on in vitro treatment with HGA, a phenomenon that could be partially counteracted by common anti-oxidant molecules. The HGA-induced oxidation of serum proteins was more relevant for albumin, haptoglobin, ceruloplasmin, and transferrin, considered as major contributors to the redox-balance of blood. When challenged with HGA, human serum showed also an increased protein thiol-oxidation.
The analysis of protein repertoires in our AKU models revealed that HGA could significantly alter the abundance of specific proteins involved in the oxidative stress response, ultimately pointing out that such an alteration, coupled with protein oxidation, may lay the basis in vivo for protein aggregation and production of ochronotic pigment.
Inflammation in AKU
Human chondrocytes treated in vitro with HGA and chondrocytes from AKU donors showed clues of lipid peroxidation, inflammation and release of pro-inflammatory cytokines. The same could be observed for cardiac valves from AKU patients, where oxidized lipids were present in co-localization with the alkaptonuric ochronotic pigment. Oxidized lipids are cytotoxic and known to attract inflammatory cells. This finding suggested a strict correlation between cytotoxicity of ochronotic pigment and inflammation.
Amyloidosis in AKU
The term “amyloid” refers to insoluble fibrous protein aggregates commonly found in some degenerative diseases. Oxidative stress, together with chronic inflammation, plays a central role for amyloid fibril formation and deposition. Our in vitro and ex vivo AKU models highlighted the amyloid nature of the HGA-related ochronotic pigment and allowed the classification of AKU as a secondary, reactive amyloidosis due to deposition of serum amyloid A (SAA).
Concluding, our studies in AKU models suggested that a vicious cycle could be generated in AKU (Fig. 1): HGA, through generation of oxidative stress and inflammation, can promote degeneration of joints. In parallel, an impaired anti-oxidant machinery can promote the aberrant production of proteins ultimately leading to secondary amyloidosis. Amyloid itself may be cytotoxic and function as a scaffold for the production of ochronotic pigment. This is an example on how establishing models to study a rare disease such as AKU might shed light onto its molecular mechanisms, helping to setting up a dedicated cure.
Braconi D, Millucci L, Bernardini G, Santucci A.
University of Siena, Dept. Biotechnology, Chemistry and Pharmacy, Siena, Italy
Oxidative stress and mechanisms of ochronosis in alkaptonuria.
Braconi D, Millucci L, Bernardini G, Santucci A.
Free Radic Biol Med. 2015 Nov
|How hepcidin, the main hormone regulating iron in… To understand how things work normally, scientists often explore diseases and through understanding how things go awry, piece together the normal orchestra of normal bodily functions. In that way, scientists…|
|L-amino acids, key for the evolution of life came… All proteins, which are functional molecules of living creatures are made by combining 20 kinds of amino acids. Except one amino acid, each amino acid has two forms (isomer) named…|
|New kojic acid-amino acid hybrids as potential… Melanogenesis is a process by which melanocytes produce melanin initiated by tyrosinase upon exposure of the skin to UV radiation. Tyrosinase plays an important role in the pathway of melanin…|
|A key molecule for embryonic bone development is… Bone is an endocrine organ with important biological functions. The skeleton produces hormones, such as FGF23 and osteocalcin, which regulate an extensive list of normal functions. Some of these functions…|
|Lipids are major players in Alzheimer’s disease Alzheimer’s disease is the most common neurodegenerative disorder affecting over 36 million people worldwide. Alzheimer’s patients suffer from dementia and memory loss and go through a progressive, irreversible and eventually…|
|A novel approach for the treatment of Juvenile… Juvenile Idiopathic Arthritis (JIA) is a leading chronic autoimmune disease in children that can result in severe disability, pain, and loss of quality of life. Similarly to what is found…|